Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product... including commentary by Symmons DPM.
| Published in: | Lancet Vol. 348; no. 9039; pp. 1413 - 1419 |
|---|---|
| Main Authors: | , , , , , |
| Format: | commentary research tables/charts Journal Article |
| Published: |
Lancet
11/23/1996
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=107278167&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 107278167 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01406736 LAN jtl: Lancet issn: 01406736 maglogo: N pubinfo: dt: 11/23/1996 vid: 348 iid: 9039 pid: 1297 pub: Lancet place: Philadelphia, Pennsylvania artinfo: ui: 107278167 107278167 1998048507 10.1016/s0140-6736(96)01254-8 NLM8937281 107278167 ppf: 1413 ppct: 6 formats: fmt: @attributes: type: T tig: atl: Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product... including commentary by Symmons DPM. aug: au: Kelly JP Kaufman DW Jurgelon JM Sheehan J Koff RS Shapiro S affil: Slone Epidemiology Unit, School of Public Health, Boston University School of Medicine, Brookline, Massachusetts 02146 sug: subj: Antiinflammatory Agents, Non-Steroidal Adverse Effects Gastrointestinal Hemorrhage Chemically Induced Aspirin Adverse Effects Case Control Studies Endoscopy, Gastrointestinal Tablets Buffers Aspirin Administration and Dosage Antiinflammatory Agents, Non-Steroidal Administration and Dosage Middle Age Adult Aged Adolescence Interviews Questionnaires Confidence Intervals Funding Source Relative Risk Logistic Regression Human Middle Aged: 45-64 years Adult: 19-44 years Aged: 65+ years Adolescent: 13-18 years pubtype: Academic Journal doctype: commentary research tables/charts Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|